Edwards Lifesciences EW Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from Edwards Lifesciences’s reported figures.
Based on trailing twelve months.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edwards Lifesciences's return on assets?
- Edwards Lifesciences (EW) reported return on assets of 8.3% in Q1 2026.
- How has Edwards Lifesciences's return on assets changed year-over-year?
- Edwards Lifesciences's return on assets decreased by 77.3% year-over-year, from 36.7% to 8.3%.
- What is the long-term trend for Edwards Lifesciences's return on assets?
- Over 4 years (2021 to 2025), Edwards Lifesciences's return on assets has grown at a 5.7% compound annual growth rate (CAGR), from 72.4% to 90.4%.
- What does return on assets mean?
- How much profit the company squeezes out of everything it owns.
- How do you interpret return on assets?
- Higher means more productive assets. Unlike ROE, it is unaffected by leverage, so a wide ROE-minus-ROA gap flags a heavily levered balance sheet.
- How does return on assets compare across companies?
- Best compared within an industry — asset intensity varies enormously across sectors. Not meaningful for banks, whose assets are largely financial.